Connexion
From injectables to pills: how the new Wegovy tablet will change the weight loss market forever
7 janvier 2026 à 07:00
The launch of an oral semaglutide pill approved for weight loss represents a new frontier for GLP-1 drugs. Katie Rosseinsky looks at how the landscape is changing
© Getty Images
